Remote Breathalyzer Market Overview
Remote Breathalyzer Market Size is estimated to reach $1.4 billion by 2027. Furthermore, it is poised to grow at a CAGR of 7.4% over the forecast period of 2022-2027. A remote Breathalyzer is a portable alcohol detection device based on electrochemical fuel cell technology that is used in the field for preliminary breath testing (PBT) or preliminary alcohol screening (PAS). A Breathalyzer tests a person's breath to see how much alcohol is in his or her system. When a person eats alcoholic beverages, alcohol is absorbed into the bloodstream via the mouth, throat, intestines, and stomach. As blood flows through the lungs, alcohol from the blood is transported to the air sacs and exhaled. As a result, the blood alcohol concentration is accurate and quick, and the instruments are portable and simple to use for Alcohol detection. Sulfuric acid, potassium dichromate, silver nitrate, and water are used in these devices to create a chemical reaction. The sulfuring acid absorbs alcohol from the air, changing the color of the solution from reddish-orange dichromate ions to green chromium ions. The presence of silver nitrate catalyzes the reaction, and the degree of color change is used to determine the amount of alcohol in the exhaled air. To compute the BAC, the standard mixture (unreacted) in the photocell system is compared to the reaction mixture.
The primary drivers driving the market's growth are rising alcohol addiction and stringent government regulations requiring mandatory alcohol testing while driving and/or in the workplace. The growing demand for remote breathalyzers around the world is estimated to boost the overall market growth of the Remote Breathalyzer Market from 2022 to 2027. Fuel cell technology is most widely used among breathalyzers.
Remote Breathalyzer Market Report Coverage
The report: “Remote Breathalyzer Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Remote Breathalyzer Market.
- Geographically, North America held a dominant market share in 2021 on account of increasing drunk driving accidents. Asia-Pacific is estimated to offer lucrative growth opportunities to the manufacturers owing to the increasing prevalence of diseases like alcoholic liver disease. The proliferation of Liver diseases is predicted to augment the market growth during the forecast period of 2022-2027.
- Growing drunk driving accidents are estimated to drive the market growth of the Remote Breathalyzer Market. The Inaccuracy owing to Remote Breathalyzer poses a threat to the market growth.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Remote Breathalyzer Market Report.
Remote Breathalyzer Market: Market Share (%) by region, 2021
Remote Breathalyzer Market Segmentation Analysis- By Technology
Remote Breathalyzer Market based on Technology can be further segmented into Fuel Cell Technology, Semiconductor Oxide Sensor Technology, Infrared Spectroscopy, and Others. Fuel cell technology held a dominant market share in the year 2021. Fuel cell technology offers a number of advantages, including small device size and low power consumption. Fuel cell-powered handheld gadgets are also available. Fuel cell breathalyzers are classified as professional level testers since they are more sensitive than other types of breathalyzers. They're also portable and deliver a highly accurate readout, boosting the Remote Breathalyzer business. Semiconductor Oxide Sensor Technology, on the other hand, is estimated to grow at a faster rate of 8.3% from 2022 to 2027, owing to the high level of accuracy and reliability it provides.
Remote Breathalyzer Market Segmentation Analysis- By Application
Remote Breathalyzer Market based on Application can be further segmented into Drug Abuse Detection, Alcohol Detection, and Others. Drug Abuse Detection held a dominant market share in the year 2021 and is estimated to be the fastest-growing, with a CAGR of 8.5% over the forecast period of 2022-2027. Remote Breathalyzers can detect a wide range of drugs, such as cocaine, morphine, methamphetamine, and marijuana, which should improve drug detection and hence grow the Remote Breathalyzer market. Breathalyzer manufacturers are also targeting opportunities arising for drug detection. Using breathalyzers for drug detection can pave the way for further adoption and drive market growth for drug abuse detection breathalyzers. The number of individual pills containing illicit fentanyl seized by law enforcement increased dramatically between January 2018 and December 2021, according to a study published in Drug and Alcohol Dependence. Moreover, as per the study published, around 290,304 drugs were seized in 2018 which have skyrocketed to touch 9,649,551 in 2021. Hence, the application for remote breathalyzers would flourish in the coming times.
Remote Breathalyzer Market Segmentation Analysis- By Geography
The Remote Breathalyzer Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 34% in the year 2021 as compared to its other counterparts on account of rising in drunk driving accidents. The National Highway Traffic Safety Administration (NHTSA) estimates that 10,142 people died in drunk driving accidents in the United States in 2019. In addition, the presence of key Remote Breathalyzer manufacturers in this region is adding to the market's growth. However, Asia-Pacific is estimated to be the fastest-growing over the forecast period of 2022-2027 on account of rising healthcare expenditure, demand for better healthcare facilities, and increasing drunk driving accidents. In India, around 8,355 road accidents were caused owing to drunk driving. However, the numbers are expected to jump up owing to the mass commercialization of alcoholic drinks and rising purchasing pattern for such forms of beverages.
Remote Breathalyzer Market Drivers
Increasing Road Accidents owing to Drunk driving Is Fueling the Remote Breathalyzer Market.
According to WHO, in 2021, Every year, around 1.3 million people's lives are cut short as a result of a traffic accident. Non-fatal injuries affect between 20 and 50 million more people, with many of them resulting in disability as a result of their injury. Individuals, their families, and nations as a whole suffer significant economic losses as a result of road traffic injuries. The cost of treatment as well as lost productivity for individuals killed or crippled by their injuries, as well as family members who must take time off work or school to care for the injured, contribute to these losses. The majority of countries lose 3% of their GDP owing to road accidents. According to NHTSA, in 2020, In the United States, roughly 28 people are killed in drunk-driving accidents every day, or once every 52 minutes. Despite the fact that this year's death rate was the lowest since 1982 when the NHTSA began tracking alcohol-related deaths, 10,142 people died. All of these deaths could have been avoided. Hence, Increasing Road accidents owing to alcohol abuse are driving the Market of Remote Breathalyzer Market
Drug abuse factor is driving the Remote Breathalyzer Market.
According to National Center for Drug Abuse Statistics (NCDAS), in 2022, 31.9 million Americans aged 12 and up are now using illegal drugs (used within the last 30 days). In the United States, 11.7 percent of people aged 12 and up use illegal substances. In the previous year, 53 million people took illegal drugs or misused prescription medications, or 19.4 percent of the population. If alcohol and cigarettes are included, 165 million Americans, or 60.2 percent of those aged 12 and over, are currently abusing drugs (i.e., used within the last 30 days). Alcohol is consumed by 139.8 million Americans aged 12 and up. Alcoholism affects 14.8 million people or 10.6% of the population. Tobacco is used by 58.8 million people. A total of 31.9 million people utilize illegal substances. Of the 25.4 percent of illegal drug users, 8.1 million have a drug problem. Opioids, which include prescription pain medicines or "pain killers" and heroin, affect 2 million people, or 24.7 percent of those with drug addictions. So, utilizing the latest remote breathalyzers to detect illegal usage of drugs like cocaine may reduce drug abuse. Hence, the Drug abuse factor is driving the Remote Breathalyzer Market.
Remote Breathalyzer Market Challenges
Inaccuracy owing to Remote Breathalyzer is restraining the Market of Remote Breathalyzer.
According to the research done by the University of Pennsylvania in 2020, devices failed to detect breath alcohol concentration (BrAC) levels of 0.08% as measured by a police-grade device more than half the time. Breathalyzers can often give erroneous findings since they can't tell the difference between alcohol and any other chemical substance with a methyl group structure. Some alcohol testing equipment can detect not only ethyl alcohol (present in alcoholic beverages) but also any chemical with a molecular structure that is comparable. Furthermore, lip gloss, mouthwash, dentures, paint, glue, thinners, cleaning solvents, hand hygiene foam, cigarettes, and even asthma inhalers can all affect the results of breathalyzers. Acetone levels in dieters and diabetics can be hundreds, if not thousands, of times greater than in the general population. Some breathalyzers can misclassify acetone and a variety of other chemicals such as alcohol. Moreover, the driver's gender, body weight, breathing patterns, hematocrit levels (the proportion of your blood volume made up of red blood cells), and body temperature are all physiological aspects that affect accuracy.
Remote Breathalyzer Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Remote Breathalyzer Market. The top 10- Remote Breathalyzer Market companies are-
- Alcohol Monitoring Systems, Inc.
- Alere, Inc.
- Abbott Laboratories
- Andatech Private Limited
- Dragerwerk AG
- Intoximeters, Inc.
- Lion Laboratories Limited
- Lifeloc Technologies
- Quest Diagnostics
- In July 2020, Lifeloc Technologies Inc, a global leader in breath alcohol testing technology, has released the LT7 and LX9, two handheld breath alcohol testers (Breathalyzers). These breath alcohol testers (Breathalyzers) are approved by the US Department of Transportation and the National Highway Traffic Safety Administration (NHTSA) for use in law enforcement and the workplace, with enhanced features that make them more user-friendly while also contributing to safer roads and communities. Bluetooth LE wireless printing for optimal operator convenience, GPS coordinates with test results, and enhanced data fields are among the features of the LX9.
- In August 2019, Abbott in collaboration with Intoximeters announced that Abbott's SoToxaTM Mobile Test System – a handheld oral fluid roadside testing solution that quickly and reliably detects recent drug use – will be marketed by Intoximeters alongside Intoximeters' Alco-Sensor® brand breath alcohol-testing products. Intoximeters' devices detect alcohol, while Abbott's SoToxa detects six drug classes, including amphetamine, benzodiazepines, cannabis (THC), cocaine, methamphetamine, and opiates.
- In March 2019, BACtrack has launched BACTrack View, a new remote monitoring service that lets friends and sponsors check-in remotely on a BACtrack user’s sobriety level. The customers being monitored will then get reminders to test their breath. The company is focusing on touting several different use cases, from recovery support to peace of mind in split-custody situations.
Report Code: HCR 46624
Report Code: HCR 0537
Report Code: HCR 0517
For more Lifesciences and Healthcare Market reports, please click here